Patent details

LUC00172 Product Name: A combination of (a) 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and (b) N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide or a pharmaceutically acceptable salt thereof

Basic Information

Publication number:
LUC00172
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP161989223
Legal Status:
Inactive
Application number:
LUC00172
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1059
Marketing Authorization Type:
Marketing Authorization Date:
24/11/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
11/08/2020
First Marketing Authorization date:
24/11/2015
Grant date:
14/12/2021
Activation date:
Publication date:
11/08/2020
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
24/11/2030
SPC Extension Expiration:
24/11/2030
Rejection date:
Withdrawal date:

Owner

From:
11/08/2020
 
 

Name:
Vertex Pharmaceuticals Incorporated
Address:
50 Northern Avenue, Boston, MA 02210, United States (US)

Agent

Name:
Dennemeyer & Associates S.A.
From:
11/08/2020
Address:
55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2020/10
Publication date:
04/09/2020
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2022/01
Publication date:
03/01/2022
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
01/01/2029
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
11/08/2020 Application Form 5
11/08/2020 Outgoing Correspondence 1
11/08/2020 General Document 3
11/08/2020 General Document 37
11/08/2020 General Document 11
11/08/2020 Publication 1
14/12/2021 Publication 1
14/12/2021 Outgoing Correspondence 1
14/12/2021 Certificate 1